MDS Patient & Family Podcast

This new initiative of the MDS Foundation is devoted to MDS patients, family members and caregivers. In each episode, experts in the field will discuss novel information on MDS, such as new diagnostic techniques, new therapies etc. They will also answer frequently asked questions.

The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.

Season 3
- Welcome to Season 3 of the MDS Patient & Family Report.
  
  Thank you to Geron, Jazz Pharmaceuticals, Merck, and Taiho Oncology for supporting this initiative.
  Season 3 : Episode 3:
  
  Introduction to cytogenetics and mutational testing in MDS
  
  Dr. Nikolaos Papadantonakis
  
  Dr. Nikolaos Papadantonakis of Winship Cancer Institute, Emory University, Atlanta, GA discusses cytogenetics and mutational testing in MDS with Dr. Hetty Carraway of Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH and Dr. Moshe Mittelman of Tel Aviv Sourasky Medical Center, Tel Aviv, Israel and how they utilize this information in the clinical setting.
  
  Learn More and Listen
- Season 3 : Episode 2:
  
  Overview of MDS treatments
  
  Dr. Nikolaos Papadantonakis
  
  Dr. Papadantonakis from Winship Cancer Institute of Emory University, Atlanta, US, and Dr. Mittelman, chairman of the MDS Foundation scientific board, discuss the range of treatment options for patients with MDS.
  
  Learn More and Listen
- Season 3 : Episode 1:
  
  New drugs for anemia of lower-risk MDS
  
  Dr. Nikolaos Papadantonakis
  
  MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.
  
  Learn More and Listen

Season 2
- Welcome to Season 2 of the MDS Patient & Family Report! We look forward to your feedback.
  Season 2 : Episode 4:
  
  Commonly asked questions – Part ll
  
  Iris Yahal
  
  Mrs. Iris Yahal, founder and director of MDS Israel Support Group (Israel MDS Foundation), discusses with Dr. Moshe Mittelman of Tel-Aviv, an MDS expert, several issues that are within the interest of MDS patients and families, including issues related to quality of life and the participation in clinical trials. http://www.mds.org.il
  
  Learn More and Listen
- Season 2 : Episode 3:
  
  Commonly asked questions – Part l
  
  Iris Yahal
  
  In this part I of the frequently asked questions episode, Mrs. Iris Yahal, the founder and director of the MDS Israel Support Group (Israel MDS foundation), asks and discusses with Dr. Mittelman, of Tel-Aviv, several topics that are within the interest of patients and families. The questions of MDS as an inherited disease or as a cancer, as well as issues related to patient-physician relationship, are discussed. http://www.mds.org.il
  
  Learn More and Listen
- Season 2 : Episode 2:
  
  Clinical Trials – What is important to know? (Part II)
  
  Noa Goldschmidt
  
  Moshe Mittelman, Professor of Medicine and Hematology from Tel-Aviv and chairman, the scientific board of MDS Foundation, interviews Mrs. Noa Goldschmidt, Chief Study Coordinator in Tel-Aviv Sourasky Medical Center, about clinical trials from the perspective of patients and families. They discuss several issues, include the three phases of trial, why the patients benefit from trials and other important points.
  
  Learn More and Listen
- Season 2 : Episode 1:
  
  Clinical trials for MDS patients – What’s important to know? (Part I)
  
  Noa Goldshmidt
  
  To kick off Season 2, Dr. Moshe Mittelman, Chief MDS Center of Excellence, Tel Aviv Sourasky (Ichilov) Medical Center, Tel-Aviv, and Mrs. Noa Goldshmidt, Chief Study Coordinator at TASMC, will discuss various issues related to clinical trials.
  
  Learn More and Listen

MDS Patient & Family Podcast

This new initiative of the MDS Foundation is devoted to MDS patients, family members and caregivers. In each episode, experts in the field will discuss novel information on MDS, such as new diagnostic techniques, new therapies etc. They will also answer frequently asked questions.

Introduction to cytogenetics and mutational testing in MDS

Dr. Nikolaos Papadantonakis

Overview of MDS treatments

Dr. Nikolaos Papadantonakis

New drugs for anemia of lower-risk MDS

Dr. Nikolaos Papadantonakis

Commonly asked questions – Part ll

Iris Yahal

Commonly asked questions – Part l

Iris Yahal

Clinical Trials – What is important to know? (Part II)

Noa Goldschmidt

Clinical trials for MDS patients – What’s important to know? (Part I)

Noa Goldshmidt

Blood transfusions and quality of life in MDS

Prof. Buckstein

Pediatric MDS

Prof. Shimamura

Personalized treatment of MDS

Drs. Rafael Bejar

MDS is Already in the Genetic Era

Prof. Guillermo Sanz

Thank you to BMS, Gilead Sciences, Inc., Jazz Pharmaceuticals Inc. and Taiho Oncology, Inc. for supporting this initiative.

CONTACT US

MEMBER OF